Diagnostic accuracy of Panbio rapid antigen tests on oropharyngeal swabs for detection of SARS-CoV-2.

Diagnostic accuracy of Panbio rapid antigen tests on oropharyngeal swabs for detection of SARS-CoV-2.
复制标题

DOI:
10.1371/journal.pone.0253321
复制
发表时间:
2021
期刊:
影响因子:
3.7
通讯作者:
Eckerle I
Eckerle I
中科院分区:
综合性期刊3区
文献类型:
--
作者:
Ngo Nsoga MT;Kronig I;Perez Rodriguez FJ;Sattonnet-Roche P;Da Silva D;Helbling J;Sacks JA;de Vos M;Boehm E;Gayet-Ageron A;Berger A;Jacquerioz-Bausch F;Chappuis F;Kaiser L;Schibler M;Renzoni A;Eckerle I

文献摘要

参考文献

被引文献

相似文献

用于检测SARS-CoV-2的抗原检测快速诊断测试(Ag-RDTs)为COVID-19大流行背景下的测试提供了新的机会。鼻咽拭子(鼻咽拭子)是参考样本类型,但口咽拭子(OPS)可能是某些患者更可接受的样本类型。我们在一个筛查中心进行了一项前瞻性研究,以评估Panbio™ COVID-19 Ag Rapid Test(Abbott)在瑞士第二波大流行期间对OPS的诊断性能,并与使用COVID-19的逆转录定量PCR(RT-qPCR)进行比较。402名门诊患者入组COVID-19筛查中心,其中168名(41.8%)患者的RT-qPCR检测结果呈阳性。与鼻咽RT-qPCR相比,口咽Ag-RDT的临床敏感性为81%(95%CI:74.2-86.6)。在234例RT-qPCR阴性个体中观察到2例假阳性,导致Ag-RDT的临床特异性为99.1%(95%CI:96.9-99.9)。对于循环阈值≤ 26.7(≥ 1 E6 SARS-CoV-2基因组拷贝数/mL,感染性病毒的假定临界值),使用OPS的Ag-RDT获得了96.3%的灵敏度(95%CI:90.7-99.0%)。根据我们的研究结果,Panbio™ Covid-19 RDT与OPS样本的诊断性能,如果由经过培训的人员采集,并且对样本质量有很高的要求,则符合WHO对Ag-RDT的标准(灵敏度≥80%,特异性≥97%),适用于有症状个体的高发病率。
Antigen-detecting rapid diagnostic tests (Ag-RDTs) for the detection of SARS-CoV-2 offer new opportunities for testing in the context of the COVID-19 pandemic. Nasopharyngeal swabs (NPS) are the reference sample type, but oropharyngeal swabs (OPS) may be a more acceptable sample type in some patients. We conducted a prospective study in a single screening center to assess the diagnostic performance of the Panbio™ COVID-19 Ag Rapid Test (Abbott) on OPS compared with reverse-transcription quantitative PCR (RT-qPCR) using NPS during the second pandemic wave in Switzerland. 402 outpatients were enrolled in a COVID-19 screening center, of whom 168 (41.8%) had a positive RT-qPCR test. The oropharyngeal Ag-RDT clinical sensitivity compared to nasopharyngeal RT-qPCR was 81% (95%CI: 74.2–86.6). Two false positives were noted out of the 234 RT-qPCR negative individuals, which resulted in a clinical specificity of 99.1% (95%CI: 96.9–99.9) for the Ag-RDT. For cycle threshold values ≤ 26.7 (≥ 1E6 SARS-CoV-2 genomes copies/mL, a presumed cut-off for infectious virus), 96.3% sensitivity (95%CI: 90.7–99.0%) was obtained with the Ag-RDT using OPS. Based on our findings, the diagnostic performance of the Panbio™ Covid-19 RDT with OPS samples, if taken by a trained person and high requirements regarding quality of the specimen, meet the criteria required by the WHO for Ag-RDTs (sensitivity ≥80% and specificity ≥97%) in a high incidence setting in symptomatic individuals.
DOI: 10.1016/j.jinf.2021.02.014
发表时间: 2021-03
期刊: The Journal of infection
影响因子: --
作者:
Bulilete O;Lorente P;Leiva A;Carandell E;Oliver A;Rojo E;Pericas P;Llobera J;COVID-19 Primary Care Research Group
通讯作者: COVID-19 Primary Care Research Group
DOI: 10.1016/j.eclinm.2020.100677
发表时间: 2021-01
期刊: EClinicalMedicine
影响因子: 15.1
作者:
Gremmels H;Winkel BMF;Schuurman R;Rosingh A;Rigter NAM;Rodriguez O;Ubijaan J;Wensing AMJ;Bonten MJM;Hofstra LM
通讯作者: Hofstra LM
DOI: 10.3389/fmed.2020.00334
发表时间: 2020-06-18
影响因子: 3.9
作者:
Wang, Huan;Liu, Qian;Xu, Shu-yun
通讯作者: Xu, Shu-yun
DOI: 10.1128/msphere.00827-20
发表时间: 2020-11-11
期刊: mSphere
影响因子: 4.8
作者:
Vetter P;Eberhardt CS;Meyer B;Martinez Murillo PA;Torriani G;Pigny F;Lemeille S;Cordey S;Laubscher F;Vu DL;Calame A;Schibler M;Jacquerioz F;Blanchard-Rohner G;Siegrist CA;Kaiser L;Didierlaurent AM;Eckerle I
通讯作者: Eckerle I
DOI: 10.1371/journal.pone.0248921
发表时间: 2021
期刊: PloS one
影响因子: 3.7
作者:
Berger A;Nsoga MTN;Perez-Rodriguez FJ;Aad YA;Sattonnet-Roche P;Gayet-Ageron A;Jaksic C;Torriani G;Boehm E;Kronig I;Sacks JA;de Vos M;Bausch FJ;Chappuis F;Renzoni A;Kaiser L;Schibler M;Eckerle I
通讯作者: Eckerle I